Neoantigenics' Unattributed Round

Neoantigenics raised a round of funding on October 22, 2013.

Neoantigenics is focused on developing oncology theranostics (therapeutic plus diagnostic) products, founded on the novel science around oocyte (egg)-associated cancer neoantigens discovered at the Un…

Articles about Neoantigenics' Unattributed Round: